Matrix metalloproteinases-2,-3 and tissue inhibitors of metalloproteinases-1,-2 in placentas from preterm pregnancies and their association with one-carbon metabolites

Reproduction

Volumn 145, Issue 4, 2013, Pages 401-410

  Sundrani, Deepali ^a   Chavan Gautam, Preeti ^a   Pisal, Hemlata ^a   Mehendale, Savita ^b   Joshi, Sadhana ^a  

^a Bharati Vidyapeeth   (India)

^b Bharati Vidyapeeth's Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FOLIC ACID; GELATINASE A; HOMOCYSTEINE; LONG CHAIN FATTY ACID; POLYUNSATURATED FATTY ACID; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRACE ELEMENT;

ADULT; ARTICLE; CARBON CYCLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FATTY ACID METABOLISM; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PLACENTA; PREMATURE LABOR; PRIORITY JOURNAL; VITAMIN METABOLISM;

ADULT; CARBON; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; INFANT, NEWBORN; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES, SECRETED; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PREMATURE BIRTH; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; YOUNG ADULT;

EID: 84877254950     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-12-0520     Document Type: Article

References (50)

1. Al Farra HY 2010 Methionine synthase polymorphisms (MTR 2756 A>G and MTR 2758 C>G) frequencies and distribution in the Jordanian population and their correlation with neural tube defects in the population of the northern part of Jordan. Indian Journal of Human Genetics 16 138-143. (doi:10.4103/0971-6866.73405)
2. Allen LH 2005 Multiple micronutrients in pregnancy and lactation: an overview. American Journal of Clinical Nutrition 81 1206S-1212S.
3. Ashworth CH & Antipatis C 2001 Micronutrient programming of development throughout gestation. Reproduction 122 527-535. (doi:10.1530/rep.0. 1220527)
4. Athayde N, Romero R, Gomez R, Maymon E, Pacora P, Mazor M, Yoon BH, Fortunato S, Menon R, Ghezzi F et al. 1999 Matrix metalloproteinases-9 in preterm and term human parturition. Journal of Maternal-Fetal Medicine 8 213-219. (doi:10.3109/147670599090 52049)
5. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, Rubens C, Menon R & Van Look PF 2010 The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bulletin of the World Health Organization 88 31-38. (doi:10.2471/BLT.08. 062554)
6. Bellayr IH, Mu X & Li Y 2009 Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Medicinal Chemistry 1 1095-1111. (doi:10.4155/fmc. 09.83)
7. Brew K & Nagase H 2010 The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochimica et Biophysica Acta 1803 55-71. (doi:10.1016/j.bbamcr. 2010.01.003)
8. Cockle JV, Gopichandran N, Walker JJ, Levene MI & Orsi NM 2007 Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications. Reproductive Sciences 14 629-645. (doi:10.1177/1933719107304563)
9. Dhobale MV, Wadhwani N, Mehendale SS, Pisal HR & Joshi SR 2011 Reduced levels of placental long chain polyunsaturated fatty acids in preterm deliveries. Prostaglandins, Leukotriens, and Essential Fatty Acids 85 149-153. (doi:10.1016/j.plefa.2011.06.003)
10. 12 and homocysteine concentrations in women delivering preterm. Annals of Nutrition and Metabolism 61 7-14. (doi:10.1159/000338473)
11. Dhobale M, Mehendale S, Pisal H, Nimbargi V & Joshi S 2012b Reduced maternal and cord nerve growth factor levels in preterm deliveries. International Journal of Developmental Neuroscience 30 99-103. (doi:10.1016/j.ijdevneu.2011.12.007)
12. Fortunato SJ, Menon R & Lombardi SJ 1999a MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. Journal of Perinatal Medicine 27 362-368. (doi:10.1515/JPM. 1999.049)
13. Fortunato SJ, Menon R & Lombardi SJ 1999b Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes. Obstetrics & Gynecology 94 435-440. (doi:10.1016/S0029-7844(99) 00336-1)
14. 12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. Journal of Pain and Symptom Management 20 93-103.
15. Goldenberg RJ, Culhane JF, Iams JD & Romero R 2008 Preterm birth 1: epidemiology and causes of preterm birth. Lancet 371 75-84. (doi:10.1016/S0140- 6736(08)60074-4)
16. Goldman S, Weiss A, Eyali V & Shaley E 2003 Differential activity of the gelatinases (matrix metalloproteinases 2 and 9) in the fetal membranes and decidua, associated with labour. Molecular Human Reproduction 9 367-373. (doi:10.1093/molehr/gag040)
17. Guo H, Lee JD, Uzui H, Yue H, Wang J, Toyoda K, Geshi T & Ueda T 2006 Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Circulation Journal 70 141-146. (doi:10.1253/circj.70.141)
18. Hayakawa T 1994 Tissue inhibitor of metalloproteinases and their cell growth-promoting activity. Cell Structure and Function 19 109. (doi:10.1247/csf.19.109)
19. Hulboy DL, Rudolph LA & Matrisian LM 1997 Matrix metalloproteinases as mediators of reproductive function. Molecular Human Reproduction 3 27-45. (doi:10.1093/molehr/3.1.27)
20. Imdad A & Bhutta ZA 2012 Maternal nutrition and birth outcomes: effect of balanced protein-energy supplementation. Paediatric and Perinatal Epidemiology 1 178-190. (doi:10.1111/j.1365-3016.2012.01308.x)
21. Ke XD, Foucault-Bertaud A, Genovesio C, Dignat-George F, Lamy E & Charpiot P 2010 Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism. Molecular and Cellular Biochemistry 335 203-210. (doi:10.1007/s11010- 009-0270-7)
22. Kundu S, Tyagi N, Sen U & Tyagi SC 2009 Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice. Molecular and Cellular Biochemistry 332 215-224. (doi:10.1007/s11010-009-0194-2)
23. Locksmith G, Clark P, Duff R & Schultz GS 1999 Amniotic fluid matrix metalloproteinase-9 levels in women with preterm labor and suspected intraamniotic infection. Obstetrics & Gynecology 94 1-6. (doi:10.1016/S0029-7844(99)00011-3)
24. Makrakis E, Grigoriou O, Kouskouni E, Vitoratos N, Salamalekis E, Chatzoudi E & Creatsas G 2003 Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in plasma/serum and urine of women during term and threatened preterm labor: a clinical approach. Journal of Maternal-Fetal and Neonatal Medicine 14 170-176. (doi:10.1080/jmf. 14.3.170.176)
25. Maymon E, Romero R, Pacora P, Gervasi MT, Bianco K, Ghezzi F & Yoon BH 2000a Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 183 914-920. (doi:10.1067/mob.2000.108879)
26. Maymon E, Romero R, Pacora P, Gervasi MT, Edwin SS, Gomez R & Seubert DE 2000b Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection. American Journal of Obstetrics and Gynecology 182 1545-1553. (doi:10.1067/mob.2000.107652)
27. Maymon E, Romero R, Pacora P, Gervasi MT, Gomez R, Edwin SS & Yoon BH 2000c Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. American Journal of Obstetrics and Gynecology 183 887-894. (doi:10.1067/mob.2000.108878)
28. Maymon E, Romero R, Pacora P, Gomez R, Mazor M, Edwin S, Chaiworapongsa T, Kim JC, Yoon BH, Menon R et al. 2001 A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) inhuman parturition, premature rupture of membranes and intraamniotic infection. Journal of Perinatal Medicine 29 308-316. (doi:10.1515/JPM.2001.044)
29. Nagase H & Woessner JF Jr 1999 Matrix metalloproteinases. Journal of Biological Chemistry 274 21491-21494. (doi:10.1074/jbc.274.31.21491)
30. Nishihara S, Someya A, Yonemoto H, Ota A, Itoh S, Nagaoka I & Takeda S 2008 Evaluation of the expression and enzyme activity of matrix metalloproteinase-7 in fetal membranes during premature rupture of membranes at term in humans. Reproductive Sciences 15 156-165. (doi:10.1177/1933719107310308)
31. Park KH, Chaiworapongsa T, Kim YM, Espinoza J, Yoshimatsu J, Edwin S, Gomez R, Yoon BH & Romero R 2003 Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. Journal of Perinatal Medicine 31 12-22. (doi:10.1515/JPM.2003.002)
32. Reister F, Kingdom JC, Ruck P, Marzusch K, Heyl W, Pauer U, Kaufmann P, Rath W & Huppertz B 2006 Altered protease expression by periarterial trophoblast cells in severe early-onset preeclampsia with IUGR. Journal of Perinatal Medicine 34 272-279. (doi:10.1515/JPM. 2006.052)
33. Ronnenberg AG, Goldman MB, Chen D, Aitken IW, Willett WC, Selhub J & Xu X 2002 Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. American Journal of Clinical Nutrition 76 1385-1391.
34. Schneider H & Miller RK 2010 Receptor-mediated uptake and transport of macromolecules in the human placenta. International Journal of Developmental Biology 54 367-375. (doi:10.1387/ijdb.082773hs)
35. Scholl TO, Hediger ML, Schall JI, Khoo CS & Fischer RL 1996 Dietary and serum folate: their influence on outcome of pregnancy. American Journal of Clinical Nutrition 63 520-525.
36. Seetharam B & Li N 2000 Transcobalamin II and its cell surface receptor. Vitamins and Hormones 59 337-366.
37. 6. Journal of Maternal-Fetal and Neonatal Medicine 23 1323-1343. (doi:10.3109/14767051003678234)
38. Solakivi T, Kunnas T, Kärkkäinen S, Jaakkola O & Nikkari ST 2009 Arachidonic acid increases matrix metalloproteinase 9 secretion and expression in human monocytic MonoMac 6 cells. Lipids in Health and Disease 8 11. (doi:10.1186/1476-511X-8-11)
39. Stygar D, Wang H, Vladic YS, Ekman G, Eriksson H & Sahlin L 2002 Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biology of Reproduction 67 889-894. (doi:10.1095/biolreprod. 102.005116)
40. Sundrani D, Chavan Gautam P, Mehendale S & Joshi S 2011 Altered metabolism of maternal micronutrients and omega 3 fatty acids epigenetically regulate matrix metalloproteinases in preterm pregnancy: a novel hypothesis. Medical Hypotheses 77 878-883. (doi:10.1016/j.mehy.2011.08.001)
41. Sundrani D, Chavan Gautam P, Pisal H, Mehendale S & Joshi S 2012 Matrix metalloproteinase-1 and -9 in human placenta during spontaneous vaginal delivery and caesarean sectioning in preterm pregnancy. PLoS ONE 7 e29855. (doi:10.1371/journal.pone.0029855)
42. Swarnakar S, Paul S, Singh LP & Reiter RJ 2011 Matrix metalloproteinases in health and disease: regulation by melatonin. Journal of Pineal Research 50 8-20. (doi:10.1111/j.1600-079X.2010.00812.x)
43. Tobin KA, Holven KB, Retterstøl K, Strøm E, Ose L, Aukrust P & Nenseter MS 2009 Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins. British Journal of Nutrition 102 1783-1789. (doi:10.1017/ S0007114509991048)
44. Tyagi N, Gillespie W, Vacek JC, Sen U, Tyagi SC & Lominadze D 2009 Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. Journal of Cellular Physiology 220 257-266. (doi:10.1002/jcp. 21757)
45. Ulug U, Goldman S, Ben-Shlomo I & Shalev E 2001 Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term deciduas and fetal membranes: the effect of prostaglandin F2a and indomethacin. Molecular Human Reproduction 7 1187-1193. (doi:10.1093/molehr/7.12.1187)
46. Visse R & Nagase H 2003 Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation Research 92 827-839. (doi:10.1161/01.RES.0000070112.80711.3D)
47. Wu G, Bazer FW, Cudd TA, Meininger CJ & Spencer TE 2004 Maternal nutrition and fetal development. Journal of Nutrition 134 2169-2172.
48. Xu P, Alfaidy N & Challis JR 2002 Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. Journal of Clinical Endocrinology and Metabolism 87 1353-1361. (doi:10.1210/jc.87.3.1353)
49. Zainal Z, Longman AJ, Hurst S, Duggan K, Caterson B, Hughes CE & Harwood JL 2009 Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthritis and Cartilage 17 896-905. (doi:10.1016/j.joca. 2008.12.009)
50. Zeydanli EN & Turan B 2009 Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta. Canadian Journal of Physiology and Pharmacology 87 1063-1073. (doi:10.1139/Y09-112)